| #58 |
Ari Mozes |
Oracle |
2 |
| #58 |
Daniel G. Brenner |
Abgenix |
2 |
| #58 |
John K. Shimmick |
Visx, Incorporated |
2 |
| #58 |
Larry L. Moresco |
Fujitsu Limited |
2 |
| #58 |
Frank Zaugg |
Zyomyx |
2 |
| #58 |
Michael J. Gormish |
Ricoh Company |
2 |
| #58 |
Gene E. Clark |
Hospira |
2 |
| #58 |
Michael A. Lutz |
Dow Corning |
2 |
| #58 |
John Miller |
Concentric Medical |
2 |
| #58 |
Robert F. Novy |
Hyperion Solutions |
2 |
| #58 |
David A. Benaron |
Spectros |
2 |
| #58 |
Louise Robinson |
Telik |
2 |
| #58 |
Gregory E. James |
NVIDIA |
2 |
| #58 |
Kenneth C. Cundy |
Xenoport |
2 |
| #58 |
Yagyensh C. Pati |
Numerical Technologies |
2 |
| #58 |
Don Gurskis |
Conceptus |
2 |
| #58 |
Jeff Callister |
Radiant Medical |
2 |
| #58 |
Alessandra Cesano |
Wistar Institute Of Anatomy And Biology |
2 |
| #58 |
Raymond Browning |
Unknown |
2 |
| #58 |
Ashok C. Popat |
— |
2 |
| #58 |
Jeffrey DiCorpo |
HP |
2 |
| #58 |
Helmut Kayan |
General Surgical Innovations |
2 |
| #58 |
Alfonso Valdes |
Sri International |
2 |
| #58 |
Rocky Arnold |
Wavezero |
2 |
| #58 |
Stephen P. Capps |
Apple |
2 |
| #58 |
Thomas Kenny |
Cooligy |
2 |
| #58 |
Milo Steven Medin |
At Home Bondholders'Liquidating Trust |
2 |
| #58 |
Robert A. Brodersen |
Siebel Systems |
2 |
| #58 |
Ioannis Pavlidis |
Hover |
2 |
| #58 |
David Lowe |
Llt International (Ireland) |
2 |
| #58 |
Christopher Becker |
Sequenom |
2 |
| #58 |
Donald Zehnder |
Nanosys |
2 |
| #58 |
John H. Martin |
Level Home |
2 |
| #58 |
Tim Lazaruk |
Agilent Technologies |
2 |
| #58 |
Conrad Sheppy |
Affymetrix |
2 |
| #58 |
Kenneth P. Gross |
Kla-Tencor |
2 |
| #58 |
Anthony Piazza, IV |
Avery Dennison |
2 |
| #138 |
Chang-Meng Hsiung |
Smiths Detection |
1 |
| #138 |
Kobi Iki |
Smith & Nephew |
1 |
| #138 |
Igal Ladabaum |
Siemens Medical Solutions Usa |
1 |
| #138 |
Joseph M. Kahn |
Stratalight Communications |
1 |
| #138 |
Ken Tsai |
Applied Materials |
1 |
| #138 |
Mark Sliwkowski |
Genentech |
1 |
| #138 |
Joseph Goldberg |
Oracle |
1 |
| #138 |
Jennifer Fraser |
Twitter |
1 |
| #138 |
Brian A. Zabel |
Millennium Pharmaceuticals |
1 |
| #138 |
Frank Chu |
Alternate Choice |
1 |
| #138 |
Scott L. Gooch |
Micron |
1 |
| #138 |
Michael Kolb |
Essential Products |
1 |
| #138 |
John F. Shanley |
Innovation |
1 |